Vermillion to Present at Leerink Global Healthcare Conference
News Feb 04, 2014
Vermillion, Inc. has been invited to present at Leerink Partners' Global Healthcare Conference. The conference will be held at the Waldorf Astoria Hotel in New York City from February 12-13, 2014.
President and CEO of Vermillion, Thomas McLain, is scheduled to present on Thursday, February 13, 2014 at 3:05 p.m. Eastern time.
He will be joined by Eric Schoen, the company's vice president of finance and chief accounting officer, for one-on-one meetings to be held throughout the day.
Management will discuss the company's initiatives to drive market adoption of OVA1®, as well as plans to expand its patient base and launch a next-generation diagnostic test.
Comments | 0 ADD COMMENT
PSA Microfluidic Assay Clinical Validation Initiated
News Jan 11, 2017